Literature DB >> 15919942

Inhibition of STAT 1 phosphorylation by human parainfluenza virus type 3 C protein.

Achut G Malur1, Santanu Chattopadhyay, Ratan K Maitra, Amiya K Banerjee.   

Abstract

The P mRNA of the viruses belonging to the subfamily Paramyxovirinae possesses a unique property of giving rise to several accessory proteins by a process that involves the utilization of overlapping open reading frames (the C proteins) and by an "RNA-editing" mechanism (the V proteins). Although these proteins are considered accessory, numerous studies have highlighted the importance of these proteins in virus transcription and interferon signaling, including our previous observation on the role of human parainfluenza virus type 3 (HPIV 3) C protein in the transcription of viral genome (Malur et al., Virus Res. 99:199-204, 2004). In this report, we have addressed its role in interferon signaling by generating a stable cell line, L-C6, by using the lentiviral expression system which expresses HPIV 3 C protein. The L-C6 cells were efficient in abrogating both alpha and gamma interferon-induced antiviral states and demonstrated a drastic reduction in the formation of gamma-activated factor complexes in the cell extracts. Western blot analysis subsequently revealed a defect in the phosphorylation of STAT 1 in these cells. Taken together, our results indicate that HPIV 3 C protein is capable of counteracting the interferon signaling pathway by specifically inhibiting the activation of STAT 1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919942      PMCID: PMC1143680          DOI: 10.1128/JVI.79.12.7877-7882.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon-beta induction and interferon signaling.

Authors:  Biao He; Reay G Paterson; Nicola Stock; Joan E Durbin; Russell K Durbin; Stephen Goodbourn; Richard E Randall; Robert A Lamb
Journal:  Virology       Date:  2002-11-10       Impact factor: 3.616

Review 2.  Paramyxovirus strategies for evading the interferon response.

Authors:  Bin Gotoh; Takayuki Komatsu; Kenji Takeuchi; Junko Yokoo
Journal:  Rev Med Virol       Date:  2002 Nov-Dec       Impact factor: 6.989

3.  V and C proteins of measles virus function as virulence factors in vivo.

Authors:  J B Patterson; D Thomas; H Lewicki; M A Billeter; M B Oldstone
Journal:  Virology       Date:  2000-02-01       Impact factor: 3.616

4.  Dephosphorylation failure of tyrosine-phosphorylated STAT1 in IFN-stimulated Sendai virus C protein-expressing cells.

Authors:  Sakura Saito; Toshio Ogino; Naoko Miyajima; Atsushi Kato; Masayoshi Kohase
Journal:  Virology       Date:  2002-02-15       Impact factor: 3.616

5.  A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryos.

Authors:  T Mebatsion; S Verstegen; L T De Vaan; A Römer-Oberdörfer; C C Schrier
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death.

Authors:  Elizabeth K Wansley; Griffith D Parks
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Role of a highly conserved NH(2)-terminal domain of the human parainfluenza virus type 3 RNA polymerase.

Authors:  Achut G Malur; Suresh K Choudhary; Bishnu P De; Amiya K Banerjee
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

Review 8.  Innate immune response against nonsegmented negative strand RNA viruses.

Authors:  Santanu Bose; Amiya K Banerjee
Journal:  J Interferon Cytokine Res       Date:  2003-08       Impact factor: 2.607

9.  Characterization of the amino acid residues of sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation.

Authors:  Atsushi Kato; Case Cortese-Grogan; Sue A Moyer; Fumihiro Sugahara; Takemasa Sakaguchi; Toru Kubota; Noriyuki Otsuki; Masayoshi Kohase; Masato Tashiro; Yoshiyuki Nagai
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  The human parainfluenza virus type 3 (HPIV 3) C protein inhibits viral transcription.

Authors:  Achut G Malur; Michael A Hoffman; Amiya K Banerjee
Journal:  Virus Res       Date:  2004-02       Impact factor: 3.303

View more
  26 in total

1.  Inflammasome Antagonism by Human Parainfluenza Virus Type 3 C Protein.

Authors:  Niraj K Shil; Swechha M Pokharel; Amiya K Banerjee; Michael Hoffman; Santanu Bose
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

2.  Suppression of STAT-1 expression by human papillomaviruses is necessary for differentiation-dependent genome amplification and plasmid maintenance.

Authors:  Shiyuan Hong; Kavi P Mehta; Laimonis A Laimins
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

3.  Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.

Authors:  Atsushi Kato; Katsuhiro Kiyotani; Toru Kubota; Tetsuya Yoshida; Masato Tashiro; Yoshiyuki Nagai
Journal:  J Virol       Date:  2007-01-10       Impact factor: 5.103

Review 4.  Pathogenesis of acute respiratory illness caused by human parainfluenza viruses.

Authors:  Henrick Schomacker; Anne Schaap-Nutt; Peter L Collins; Alexander C Schmidt
Journal:  Curr Opin Virol       Date:  2012-03-03       Impact factor: 7.090

5.  Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect.

Authors:  Machiko Nishio; Masato Tsurudome; Morihiro Ito; Yasuhiko Ito
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  Measles virus circumvents the host interferon response by different actions of the C and V proteins.

Authors:  Yuichiro Nakatsu; Makoto Takeda; Shinji Ohno; Yuta Shirogane; Masaharu Iwasaki; Yusuke Yanagi
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Human ribosomal protein L13a is dispensable for canonical ribosome function but indispensable for efficient rRNA methylation.

Authors:  Sujan Chaudhuri; Keyur Vyas; Purvi Kapasi; Anton A Komar; Jonathan D Dinman; Sailen Barik; Barsanjit Mazumder
Journal:  RNA       Date:  2007-10-05       Impact factor: 4.942

8.  Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB.

Authors:  Sudhiranjan Gupta; David Young; Ratan K Maitra; Anasuya Gupta; Zoran B Popovic; Sandro L Yong; Anjuli Mahajan; Qing Wang; Subha Sen
Journal:  J Mol Biol       Date:  2007-10-10       Impact factor: 5.469

9.  Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium.

Authors:  Emmalene J Bartlett; Margaret Hennessey; Mario H Skiadopoulos; Alexander C Schmidt; Peter L Collins; Brian R Murphy; Raymond J Pickles
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

10.  Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor.

Authors:  Grégory Caignard; Anastassia V Komarova; Mehdi Bouraï; Thomas Mourez; Yves Jacob; Louis M Jones; Flore Rozenberg; Astrid Vabret; François Freymuth; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  PLoS Pathog       Date:  2009-09-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.